enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The Terrible—and Amazing—Side Effects of Weight Loss Drugs

   www.aol.com/terrible-amazing-side-effects-weight...

   GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now ...

3. Gelesis100 - Wikipedia

   en.wikipedia.org/wiki/Gelesis100

   The US Food and Drug Administration approved the use of Gelesis100 in April 2019 as a medical device. [4] Gelesis100 is the first treatment of its kind for overweight and obesity. [ 2 ] In 2022, the American Gastroenterology Association published a guideline for the management of obesity, which recommended the use of Gelesis100 be limited to ...

4. FDA warns companies over unapproved weight loss drug sales - AOL

   www.aol.com/news/fda-warns-companies-over...

   The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...

5. US FDA warns online vendors selling unapproved weight-loss drugs

   www.aol.com/news/us-fda-warns-online-vendors...

   The letters were issued to Xcel Peptides, Swisschems, Summit Research and Prime Peptides last week after the U.S. health regulator conducted a review of their respective websites in October. The ...

6. Gelesis - Wikipedia

   en.wikipedia.org/wiki/Gelesis

   Gelesis is a biotechnology company located in Boston, Massachusetts that developed the weight loss device Gelesis100 (Plenity) for use in overweight and obesity.The company produces Gelesis100, which is a superabsorbent hydrogel capsule that expands in the stomach, creating a feeling of fullness, helping people reduce the amount of food they eat.

7. The Zepbound Shortage Is Over — Here's What to Expect ... - AOL

   www.aol.com/zepbound-shortage-over-heres-expect...

   Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...